Liz Johnstone is a Lecturer in the UWA School of Biomedical Sciences, and is also the Molecular Endocrinology Lead in the Molecular Endocrinology and Pharmacology Lab at the Harry Perkins Institute of Medical Research. Liz is currently a Board Director of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), an Early Career Committee Member of the International Union of Pharmacology and a Council Member of the Endocrine Society of Australia (ESA). Liz has recently been awarded the British Pharmacological Society/ASCEPT Outstanding Young Investigator Prize (2024), the Bellberry New Investigators Award (2024) and the ESA Early Career Contribution to Endocrinology Award (2025).

Dr. Ammar Khalid is a Senior Resident in the Department of Pharmacology at Jawaharlal Nehru Medical College & Hospitals, Aligarh Muslim University, India. He holds an MD in Pharmacology. His research focuses on clinical Pharmacology, nanomedicine, and anticancer drug development, with a particular interest in nanoparticulate drug delivery systems for improving therapeutic efficacy and safety.

So Jin Lee, Pharm.D., Ph.D. is a pharmacometrician and Co-founder/CEO/CTO of APLUS Simulation based in Seoul, Korea, specializing in AI-powered PK/PD and semi-mechanistic modeling for biologics, bispecific antibodies, and cell and gene therapy. She also serves as an Affiliated Professor at Sungkyunkwan University School of Pharmacy, where she teaches pharmacometrics and clinical pharmacology. Dr. Lee has led more than a decade of modeling-supported drug development across global regulatory landscapes, contributing to IND/NDA/BLA submissions to MFDS, FDA, and EMA while advancing NAMs-aligned in silico methodologies. Her research focuses on quantitative translational modeling and AI integration for MIDD, with multiple first-author publications and invited lectures at national and international conferences. She is actively pioneering AI-enabled frameworks to accelerate human-centered, non-animal drug development approaches globally.

Dr Shin Liau is a pharmacist and Research Fellow at the Centre for Medicine Use and Safety, Monash University. She leads work on optimising medication management for older adults living with frailty in community and residential aged care settings across Australia, Asia and Europe. With a strong commitment to improving medication safety and effectiveness, her current research addresses the unique challenges of appropriate prescribing by integrating deprescribing recommendations in clinical practice guidelines.

Dr Stefanie Lip is a Clinical Senior Lecturer at the University of Glasgow and an Honorary Consultant in General Internal Medicine & Clinical Pharmacology and Therapeutics at the Queen Elizabeth University Hospital (NHS Greater Glasgow & Clyde). Her research focuses on pharmacogenomics and hypertension.

Dr Hornaday is a Postdoctoral Fellow in the Department of Physiology & Pharmacology. Her research involves investigating biomarkers for the prediction of preterm birth and investigating mechanisms underlying spontaneous preterm birth.